Feature

Video

Sponsored

Looking Towards the Future of CAR T-cell Trials

Delivering the same safe product to a patient while improving timelines of clinical trials

The panelists explain how they hope CAR T-cell clinical trials will improve over time. Tactics like developing scalable manufacturing techniques, having adaptive manufacturing, streamlining regulatory approval, and gaining early feedback from regulatory bodies will help quicken clinical trial processes. 

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Videos